Recent Studies Tap Into AACR Project GENIE Registry
The AACR Project Genomics Evidence Neoplasia Information Exchange (AACR Project GENIE) is a unique registry that aggregates, harmonizes, and...
The AACR Project Genomics Evidence Neoplasia Information Exchange (AACR Project GENIE) is a unique registry that aggregates, harmonizes, and...
During late spring and early summer, the U.S. Food and Drug Administration (FDA) approved four new molecularly targeted therapeutics—alpelisib...
Cancer is very complex, and the tools that we need to understand how it develops and progresses come from...
As a monthly staple on this blog, we feature the editors’ picks from the 10 journal issues published by...
This spring, in the inaugural year of the American Association for Cancer Research (AACR) Global-Scholar-In-Training Awards (GSITA) program, 15...
Since 2011, immunotherapy has emerged as an exciting new approach to cancer treatment that is yielding unprecedented, durable responses...
Building on advances in technology and analytical tools, real-world data (RWD) sources have attracted increasing interest as means to...
Rare cancers, when taken all together, make up an estimated 20 to 25 percent of all cancers diagnosed. With...
Every two minutes, a woman somewhere in the world dies of cervical cancer. That harrowing statistic, shared by Anna R....
Every person who hears the words “you have cancer” has a unique story. As part of Cancer Today’s mission...